ABATE AS INDUSTRIES LIMITED

BSE: ABATEAS531658ISIN INE454E01013

Healthcare
Hospital

Share price

₹6.70+0.13 (+1.98%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

31 Jul 2025 · Bonus 1:1

52W high: ₹20.11
52W low: ₹6.16
Off 52W high: -66.68%
1M return: -11.61%
3M return: -31.28%
6M return: -35.82%
1Y return: -61.00%
20D avg volume: 29,779
50 DMA: ₹7.99
200 DMA: ₹10.34

Key ratios Consolidated

Market cap: ₹105.60 Cr
Current price: ₹6.70
52W high / low: ₹20.11 / ₹6.16
Face value: ₹10.00
P/E: 0.00
P/B: 0.61
EPS (TTM): ₹0.00
Book value / share: ₹11.00
ROE: —
ROCE: 6.60%
Operating margin: —
Net margin: —
Debt / equity: 0.05
Net debt: ₹6.01 Cr
Interest cover: 23.68
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 69.1 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	22.82	33.94	42.69	42.13	41.06	14.09	—
	0.26	0.48	0.05	0.97	0.42	0.97	—
	23.07	34.42	42.74	43.10	41.48	15.05	—
	20.36	31.49	39.42	38.97	39.16	13.87	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	12.33	23.01	34.16	33.15	33.94	11.09	—
	2.11	2.08	2.01	1.86	2.20	0.83	—
	0.14	0.13	0.15	0.17	0.11	0.06	—
	0.74	0.52	0.52	0.52	0.49	0.55	—
	4.81	4.41	4.29	4.42	4.70	1.45	—
	2.71	2.93	3.32	4.13	2.32	1.18	—
	0.00	0.00	0.01	0.16	0.00	0.00	—
	2.71	2.93	3.33	4.29	2.32	1.18	—
	0.48	0.06	0.27	0.23	0.16	-0.01	—
	2.24	2.93	3.06	4.07	2.25	1.19	—
	0.08	0.13	0.13	0.19	0.19	0.15	—
Key metrics
	3.59	3.58	4.00	4.98	2.92	1.79	—
	15.70%	10.50%	9.40%	11.80%	7.10%	12.70%	—
	9.80%	8.60%	7.20%	9.70%	5.50%	8.40%	—
	—	1.50%	—	2.30%	—	0.70%	—
	-44.40%	140.90%	—	—	—	—	—
	-0.40%	146.20%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	141.58	159.41	14.09	—
	1.76	2.33	0.97	—
	143.33	161.74	15.05	—
	130.24	149.03	13.96	—
	0.00	0.00	0.00	—
	102.65	124.26	11.09	—
	8.06	8.14	0.86	—
	0.59	0.56	0.06	—
	2.30	2.04	0.55	—
	17.93	17.82	1.51	—
	13.09	12.70	1.09	—
	0.17	0.00	0.00	—
	13.26	12.70	1.09	—
	1.04	0.72	-0.01	—
	12.30	12.30	1.10	—
	0.53	0.54	0.14	—
Key metrics
	16.15	15.30	1.70	—
	11.41%	9.60%	12.10%	—
	8.69%	7.70%	7.80%	—
	—	6.60%	0.60%	—
	—	1,031.40%	—	—
	—	1,018.20%	—	—
	—	3.11	-0.73	—
	—	0.50	-0.63	—
	—	0.05	0.06	—
	—	6.01	8.88	—
	—	69.1	589.6	—
Balance sheet
	—	222.93	205.65	—
	—	57.41	42.11	—
	—	3.54	1.61	—
	—	25.87	16.61	—
	—	16.24	12.45	—
	—	8.31	7.95	—
	—	19.54	16.77	—
	—	11.94	6.30	—
	—	21.06	15.81	—
	—	9.55	10.49	—
	—	7.53	7.04	—
	—	2.02	3.45	—
	—	199.33	185.99	—
Cash flow
	—	6.13	-0.69	—
	—	-3.02	-164.43	—
	—	-2.43	164.66	—
	—	3.02	0.04	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.25	0.36	0.41	0.95	0.40	0.97	—	—	—	—
	0.25	0.36	0.41	0.95	0.40	0.97	—	—	—	—
	0.11	0.11	0.09	0.11	0.27	0.34	0.02	0.03	0.04	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.02	0.02	0.02	0.02	0.02	0.02	—	0.01	0.02	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.09	0.09	0.07	0.09	0.25	0.32	—	0.02	0.02	—
	0.14	0.25	0.32	0.84	0.14	0.63	-0.02	-0.03	-0.04	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	0.14	0.25	0.32	0.84	0.14	0.63	-0.02	-0.03	-0.04	—
	0.00	0.00	0.04	0.00	0.00	0.00	—	—	—	—
	0.14	0.25	0.28	0.84	0.14	0.63	-0.02	-0.03	-0.04	—
	0.01	0.02	0.02	0.05	0.02	0.08	-0.05	-0.05	-0.07	—
Key metrics
	0.14	0.25	0.32	0.84	0.14	0.63	-0.02	-0.03	-0.04	—
	—	0.20%	—	0.50%	—	0.40%	—	—	—	—
	0.00%	-60.30%	1,500.00%	2,900.00%	450.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.00	0.00	0.00	—
	1.97	2.12	0.97	—
	1.97	2.12	0.97	—
	0.42	0.57	0.43	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.08	0.07	0.05	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.34	0.50	0.38	—
	1.55	1.55	0.54	—
	0.00	0.00	0.00	—
	1.55	1.55	0.54	—
	0.04	0.00	0.00	—
	1.51	1.55	0.54	—
	0.10	0.10	0.08	—
Key metrics
	1.55	1.55	0.54	—
	78.68%	—	—	—
	76.65%	—	—	—
	—	0.90%	0.30%	—
	109.72%	187.00%	—	—
	—	0.87	-0.42	—
	—	0.56	-0.78	—
	—	0.01	0.01	—
	—	1.54	1.57	—
Balance sheet
	—	166.45	165.80	—
	—	1.96	1.30	—
	—	0.05	0.01	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.27	0.24	—
	—	0.00	0.00	—
	—	0.03	0.00	—
	—	0.12	1.76	—
	—	1.59	1.58	—
	—	0.00	1.58	—
	—	1.59	0.00	—
	—	164.75	164.04	—
Cash flow
	—	0.87	-0.42	—
	—	0.00	0.00	—
	—	-0.83	0.36	—
	—	0.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): +109.72%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 32.40%

Quarter	30 Sep 2026	September 2026	June 2026
Promoter %	32.40%	32.40%	32.40%

Holder	Type	Holding	Previous	Change
Abdul Karim Meerakutty Pazhariyi	Public	14.30%	14.30%	0.00%
Shireen M T	Public	14.17%	14.17%	0.00%
Fazil Chemmankuzhiyil	Public	10.12%	10.12%	0.00%
HALIK MUSTHAFA K .	Promoter	4.81%	4.81%	0.00%
SOUTH BAZAR OPTICALS AND VISION CENTRE	Promoter Group	4.79%	4.79%	0.00%
ASYA	Promoter Group	4.50%	4.50%	0.00%
SHAHID ARIKUZHIYIL	Promoter	4.26%	4.26%	0.00%
ABAL HEALTHCARE	Promoter Group	3.87%	3.87%	0.00%
SAMSUDEEN ARIKUZHIYAN	Promoter	2.50%	2.50%	0.00%
MALAPPURAM OPTICALS AND VISION CENTRE LIMITED LIABILITY	Promoter Group	1.41%	1.41%	0.00%
AL SALAMA EYE RESEARCH FOUNDATION	Promoter Group	1.16%	1.16%	0.00%
MUHEMMED SWADIQUE	Promoter	1.03%	1.03%	0.00%
MANJERI OPTICALS AND VISION CENTRE LIMITED LIABILITY	Promoter Group	0.91%	0.91%	0.00%
MOHAMMEDKUTTY A .	Promoter Group	0.73%	0.73%	0.00%
MUSALLYARAKATHARAKKAL SAFARULLA	Promoter	0.71%	0.71%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Apollo Hospitals Enterprises Ltd.	1,23,324	8,577.00	56.78	19.50%	+19.24% TTM	+35.20% TTM	+9.78%
Max Healthcare Institute Limited	90,129	926.00	65.28	12.70%	+15.17% TTM	+1.73% TTM	-18.59%
Manipal Health Enterprises Limited	87,828	667.70	—	—	—	—	—
ASTER DM QUALITY CARE LIMITED	62,665	718.90	172.72	10.20%	+15.70% TTM	+3.89% TTM	+4.39%
Fortis Healthcare Ltd	59,710	790.90	55.79	12.00%	+17.50% TTM	+18.62% TTM	-22.35%
Narayana Hrudayalaya Limited	39,427	1,929.30	45.89	11.40%	+71.40% TTM	+1.61% TTM	+5.41%
Global Health Limited	37,682	1,401.45	61.46	15.00%	+26.18% TTM	+9.16% TTM	+12.21%
Krishna Institute of Medical Sciences Limited	31,074	739.85	159.85	8.20%	+30.90% TTM	-51.92% TTM	+3.15%
Dr. Agarwal's Health Care Limited	16,618	524.15	89.77	9.70%	—	—	+1.80%
Rainbow Children's Medicare Limited	12,990	1,278.95	43.51	16.80%	+22.83% TTM	+17.12% TTM	-8.02%
PARK MEDI WORLD LIMITED	9,958	230.55	—	18.10%	—	—	—
YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITED	9,900	1,027.45	54.50	11.00%	+50.40% TTM	+19.12% TTM	+25.09%
HealthCare Global Enterprises Limited	9,286	621.95	279.19	6.90%	+13.77% TTM	-19.23% TTM	—
Jupiter Life Line Hospitals Limited	9,178	279.95	49.57	13.80%	+16.71% TTM	-6.85% TTM	-9.74%
Paras Healthcare Limited	8,135	751.85	—	—	—	—	—
Kovai Medical Center & Hospital Ltd S	6,561	5,996.35	25.97	20.60%	+14.96% TTM	+16.29% TTM	-1.95%
Artemis Medicare Services Limited	4,758	300.60	41.36	13.70%	+14.77% TTM	+21.46% TTM	+22.59%
Indraprastha Medical Corporation Lt S	3,092	337.25	16.09	30.70%	+10.72% TTM	+9.95% TTM	-44.21%
Dr.Agarwals Eye Hospital Ltd. S	2,616	5,413.80	34.33	16.10%	+20.01% TTM	+31.87% TTM	+2.39%
KMC Speciality Hospitals India Limited S	2,453	150.40	43.98	24.60%	+35.05% TTM	+137.83% TTM	+118.35%
Shalby Limited	1,336	123.70	35.06	7.90%	+7.27% TTM	+17,422.73% TTM	-49.15%
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED	1,260	159.75	75.29	8.60%	—	—	—
GPT Healthcare Limited S	1,152	140.45	24.38	16.40%	+18.07% TTM	-0.78% TTM	-5.48%
Rays of Belief Limited	528	252.45	—	—	—	—	—
ASARFI HOSPITAL LIMITED	347	176.40	—	18.40%	—	—	+22.97%
ABATE AS INDUSTRIES LIMITED	106	6.70	—	6.60%	—	—	-61.00%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Submission of Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, for service agreement entered into with Franchise India Brands Limited.14 Oct 2026 · Company Update / Memorandum of Understanding /Agreements
Submission of certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30 September 2026.13 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Intimation of closure of trading window29 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of Scrutinizer Report of Abate AS Industries Limited pertaining to AGM held on 16.09.2026.17 Sep 2026 · AGM/EGM / AGM
Submission of Proceedings of the Annual General Meeting held on 16.09.2026.16 Sep 2026 · AGM/EGM / AGM
Submission of post dispatch Newspaper Publication for the 35th Annual General Meeting of the Company24 Aug 2026 · Company Update / Newspaper Publication
Submission of Notice of Annual General Meeting to be held on 16th September 2026.22 Aug 2026 · AGM/EGM / AGM
Submission of Intimation as per the subject.22 Aug 2026 · Company Update / General
Submission of Intimation of Record date.22 Aug 2026 · Corp. Action / Record Date
Submission of Intimation of AGM date, Book Closure Date and cut-off date.22 Aug 2026 · Corp. Action / Book Closure
Submission of Annual Report along with Notice for the Financial Year 2025-26.22 Aug 2026 · Others / Reg. 34 (1) Annual Report
Submission of pre-dispatch Newspaper Publication Advertisement for the 35th Annual General Meeting of the company.21 Aug 2026 · Company Update / Newspaper Publication
Submission of Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June 2026.18 Aug 2026 · Company Update / General
Disclosure under Regulation 30 - Proposed Alteration of Clause III A (Main object clause) of the Memorandum of Association.13 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
Reappointment of Dr Muhammed Swadique (DIN:02933064) as Executive Director from August 14, 2026, to August 13, 2031, Ms Julie G Varghese (DIN: 09274826) as Independent Director from August ....13 Aug 2026 · Company Update / Change in Directorate
Appointment of Mr Aboobakar Vattamkandathil (DIN:10059868) as an additional director (Independent Director) of the company with effect from 13.08.2026.13 Aug 2026 · Company Update / Change in Directorate
Submission of unaudited financial results (standalone & consolidated) for the quarter ended 30 June 2026.13 Aug 2026 · Result / Financial Results
Submission of the outcome of the board meeting held on 13.08.202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
Abate As Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial results ....10 Aug 2026 · Board Meeting / Board Meeting
Submission of certificate under 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31 June 2026.3 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation for Closure of Trading Window for the quarter ended 30th June, 2026.23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of detailed Independent Auditor''s Report in response to BSE query dated 11th June, 2026.11 Jun 2026 · Company Update / General
Announcement under Regulation 30 (LODR)- Earning Call Transcript4 Jun 2026 · Company Update / Earnings Call Transcript
Submission of Newspaper Publication of Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026.1 Jun 2026 · Company Update / Newspaper Publication
Appointment of M/s Sasi Vijayan & Rajan as Internal Auditor of the company for the financial year 2026-2729 May 2026 · Company Update / General
Submission of Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2026.29 May 2026 · Result / Financial Results
Submission of Outcome of the Board Meeting held on Friday, 29th May,202629 May 2026 · Board Meeting / Outcome of Board Meeting
Submission of Annual Secretarial Compliance Report for the year ended 31st March 2026.29 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Abate As Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial statements ....25 May 2026 · Board Meeting / Board Meeting
Submission of Scrutinizer report and Postal ballot dated 9th may 202611 May 2026 · AGM/EGM / Postal Ballot
Disclosure under Reg 30 - Appointment of Mr.Harikumar V as Non executive Independent Director of the Company11 May 2026 · Company Update / Change in Management
Submission of Scrutinizer report and voting results of Postal Ballot dated 9th may 202611 May 2026 · AGM/EGM / Postal Ballot
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NPMED Healthcare LLP20 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Submission of newspaper advertisement13 Apr 2026 · Company Update / Newspaper Publication
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....8 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Submission of Notice of Postal Ballot dated 8th April 20268 Apr 2026 · AGM/EGM / Postal Ballot
Submission of Circular resolution passed by the Board of Directors dated 8th April 20268 Apr 2026 · Company Update / General
Submission of Compliance certificate under Regulation under 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ASYA6 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fazil Chemmankuzhiyal6 Apr 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Corporate actions

Purpose	Ex date	Record date	Payment date
Bonus issue 1:1	31 Jul 2025	31 Jul 2025	—

Board meetings

13 Aug 2026 Board Meeting - Financial Results